Form 4 for RNAC Cartesian Therapeutics, Inc.
Accepted 2021-12-03 00:00:00 ET · period of report 2021-12-01 · accession 0001453687-21-000158 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-12-03 | 2021-12-01 | RNAC | Brunn Carsten | Pres, CEO, Dir | M - OptEx | $0.00 | +10.9K | 289.7K | +4% | $0 |
| D | 2021-12-03 | 2021-12-02 | RNAC | Brunn Carsten | Pres, CEO, Dir | S - Sale+OE | $2.96 | -4,746 | 285.0K | -2% | -$14.0K |
| D | 2021-12-03 | 2021-12-01 | RNAC | Brunn Carsten | Pres, CEO, Dir | M - OptEx | $0.00 | -10.9K | 43.8K | -20% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-01 | M | A | 10,938 | $0.00 | 289,697 | D | — | — | |
| 2 | Common | Common Stock | 2021-12-02 | S | D | 4,746 | $2.96 | 284,951 | D | — | — | (F2) The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $2.94 to $2.99. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 3 | Derivative | Restricted Stock Units | 2021-12-01 | M | D | 10,938 | $0.00 | 43,750 | D | — · — to — | 10,938 Common Stock | (F3) Each restricted stock unit represents a contingent right to receive one share of common stock. (F4) This restricted stock unit vested as to 25% on December 1, 2019 and has vested, and will continue to vest, as to an additional 8.33% each quarter thereafter until fully vested. The restricted stock units have no expiration date. |